Total Payments
$33,446
2024 Payments
$2,078
Companies
67
Transactions
612
Medicare Patients
4,789
Medicare Billing
$627,205
Payment Breakdown by Category
Other$18,800 (56.2%)
Food & Beverage$12,409 (37.1%)
Travel$2,115 (6.3%)
Education$122.04 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,800 | 14 | 56.2% |
| Food and Beverage | $12,409 | 574 | 37.1% |
| Travel and Lodging | $2,115 | 16 | 6.3% |
| Education | $122.04 | 8 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $22,453 | 87 | $0 (2021) |
| Astellas Pharma US Inc | $1,632 | 75 | $0 (2024) |
| ABBVIE INC. | $1,151 | 48 | $0 (2024) |
| Boston Scientific Corporation | $742.42 | 45 | $0 (2024) |
| Janssen Biotech, Inc. | $616.25 | 28 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $596.64 | 27 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $523.24 | 25 | $0 (2024) |
| PFIZER INC. | $504.36 | 36 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $435.92 | 14 | $0 (2024) |
| ACCORD HEALTHCARE, INC. | $399.98 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,078 | 86 | ABBVIE INC. ($460.70) |
| 2023 | $1,763 | 77 | AbbVie Inc. ($257.63) |
| 2022 | $1,094 | 44 | Astellas Pharma US Inc ($211.27) |
| 2021 | $4,383 | 37 | Allergan, Inc. ($3,828) |
| 2020 | $2,878 | 47 | Allergan, Inc. ($2,266) |
| 2019 | $6,061 | 127 | Allergan Inc. ($4,130) |
| 2018 | $13,734 | 112 | Allergan Inc. ($12,110) |
| 2017 | $1,455 | 82 | Astellas Pharma US Inc ($366.37) |
All Payment Transactions
612 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/19/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $22.43 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $21.84 | General |
| Category: Prostate cancer | ||||||
| 12/05/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $42.86 | General |
| Category: Urology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: HORMONE THERAPY | ||||||
| 11/21/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: rezum_URO | ||||||
| 11/20/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $28.18 | General |
| 11/18/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Urology | ||||||
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Oncology | ||||||
| 11/05/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: HORMONE THERAPY | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $101.59 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Oncology | ||||||
| 10/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/18/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: Prostate cancer | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/07/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,214 | 9,458 | $628,063 | $175,511 |
| 2022 | 14 | 1,071 | 9,057 | $537,820 | $155,307 |
| 2021 | 15 | 1,299 | 7,584 | $514,479 | $164,494 |
| 2020 | 17 | 1,205 | 8,057 | $453,855 | $131,893 |
Total Patients
4,789
Total Services
34,156
Medicare Billing
$627,205
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 277 | 408 | $147,288 | $39,432 | 26.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 26 | 8,000 | $112,000 | $38,766 | 34.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 129 | 144 | $100,080 | $28,329 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 213 | 213 | $100,110 | $26,137 | 26.1% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 27 | 51 | $57,477 | $15,106 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 117 | 146 | $37,230 | $10,056 | 27.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 15 | 18 | $24,171 | $5,913 | 24.5% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 19 | 19 | $17,347 | $4,865 | 28.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 206 | 240 | $12,240 | $2,080 | 17.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 44 | $7,040 | $2,030 | 28.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 12 | 12 | $6,972 | $1,422 | 20.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 11 | $5,196 | $866.98 | 16.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 132 | 152 | $912.00 | $508.09 | 55.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 27 | 7,800 | $109,200 | $37,212 | 34.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 100 | 120 | $81,672 | $22,884 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 166 | 166 | $77,162 | $22,109 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 220 | $77,816 | $21,143 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 178 | 228 | $57,185 | $16,106 | 28.2% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2022 | 27 | 49 | $55,223 | $15,319 | 27.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 18 | 20 | $25,170 | $6,599 | 26.2% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2022 | 24 | 25 | $22,807 | $6,369 | 27.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 53 | 72 | $11,050 | $3,311 | 30.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 149 | 182 | $9,282 | $1,541 | 16.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $4,073 | $1,110 | 27.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 13 | 13 | $6,006 | $1,098 | 18.3% |
About Dr. Sara Spettel, MD
Dr. Sara Spettel, MD is a Urology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1750544243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Spettel, MD has received a total of $33,446 in payments from pharmaceutical and medical device companies, with $2,078 received in 2024. These payments were reported across 612 transactions from 67 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,800).
As a Medicare-enrolled provider, Spettel has provided services to 4,789 Medicare beneficiaries, totaling 34,156 services with total Medicare billing of $627,205. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Portland, OR
- Active Since 07/07/2008
- Last Updated 02/20/2014
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1750544243
Products in Payments
- BOTOX (Biological) $19,096
- BOTOX (Drug) $3,998
- XTANDI (Drug) $1,105
- Myrbetriq (Drug) $591.33
- PROVENGE (Drug) $537.89
- ORGOVYX (Drug) $419.68
- Erleada (Drug) $412.57
- CAMCEVI (Drug) $399.98
- Xofigo (Drug) $392.50
- REZUM (Device) $375.73
- ELIGARD (Drug) $285.63
- Xtandi (Drug) $284.36
- XIAFLEX (Biological) $246.28
- ZYTIGA (Drug) $220.75
- BOTOX THERAPEUTIC (Biological) $209.57
- Nubeqa (Drug) $204.14
- ERLEADA (Drug) $183.13
- NOCDURNA (Drug) $179.55
- XGEVA (Biological) $169.62
- GEMTESA (Drug) $162.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Portland
Dr. Lance Marr, M.d, M.D
Urology — Payments: $277,964
Urology $277,964
Dr. Geolani Dy, M.d, M.D
Urology — Payments: $69,493
Urology $69,493
Jyoti Chouhan, Do, Pharmd, DO, PHARMD
Urology — Payments: $62,636
Urology $62,636
David Sobel, Md, MD
Urology — Payments: $41,221
Urology $41,221
Dr. James Tycast, M.d, M.D
Urology — Payments: $38,374
Urology $38,374
Amir Patel
Urology — Payments: $35,329
Urology $35,329